These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 6445044
1. Lack of evidence that the central serotoninergic system plays a role in the activation of prolactin secretion following inhibition of dopamine synthesis or blockade of dopamine receptors in the male rat. Krulich L, Coppings RJ, Giachetti A, McCann SM, Mayfield MA. Neuroendocrinology; 1980; 30(3):133-8. PubMed ID: 6445044 [Abstract] [Full Text] [Related]
2. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine. Krulich L, McCann SM, Mayfield MA. Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261 [Abstract] [Full Text] [Related]
3. The influence of antiserotonergic agents on the action of dopaminergic drugs. Mogilnicka E, Scheel-Krüger J, Klimek V, Golembiowska-Nikitin K. Pol J Pharmacol Pharm; 1977 Apr; 29(1):31-8. PubMed ID: 140371 [Abstract] [Full Text] [Related]
4. The influence of serotonergic agents on the body temperature. Pawlowski L. Pol J Pharmacol Pharm; 1976 Apr; 28(6):615-23. PubMed ID: 138132 [Abstract] [Full Text] [Related]
5. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion. Bero LA, Kuhn CM. J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276 [Abstract] [Full Text] [Related]
6. Effect of serotonin antagonists on prolactin and progesterone secretion in rats: evidence that the stimulatory and inhibitory actions of serotonin on prolactin release may be mediated through different receptors. Jahn GA, Deis RP. J Endocrinol; 1988 Jun; 117(3):415-22. PubMed ID: 2969029 [Abstract] [Full Text] [Related]
12. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan. Jørgensen H, Knigge U, Warberg J. Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914 [Abstract] [Full Text] [Related]
14. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat. Krulich L, Vijayan E, Coppings RJ, Giachetti A, McCann SM, Mayfield MA. Endocrinology; 1979 Jul; 105(1):276-83. PubMed ID: 446410 [No Abstract] [Full Text] [Related]
15. Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications. Müller EE, Locatelli V, Cella S, Peñalva A, Novelli A, Cocchi D. Drugs; 1983 Apr; 25(4):399-432. PubMed ID: 6133737 [Abstract] [Full Text] [Related]
17. Effect of 5-hydroxytryptophan on prolactin and growth hormone release in the infant rat: evidence for different neurotransmitter mediation. Cocchi D, Gil-Ad I, Panerai AE, Locatelli V, Müller EE. Neuroendocrinology; 1977 Apr; 24(1):1-13. PubMed ID: 23503 [Abstract] [Full Text] [Related]